M
The startup develops a rapid antigen test that utilizes bioinformatics, genomics, and molecular microbiology to identify novel viruses through DNA fingerprint analysis. This technology enables healthcare providers to efficiently detect and monitor emerging pathogens, enhancing public health response capabilities.
Updated 3 months ago
Funding
$14M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a rapid antigen test that utilizes bioinformatics, genomics, and molecular microbiology to identify novel viruses through DNA fingerprint analysis. This technology enables healthcare providers to efficiently detect and monitor emerging pathogens, enhancing public health response capabilities.